A quality system can look spotless on paper and still fall apart the second an inspector starts asking real questions.
Dr. Marcela Fialova, our Co-Founder and COO, sat down with Lucia Matejkinova, our QA Director, to talk about the three things that actually decide whether a pharmacovigilance quality system holds up: how to think about deviations, what makes a corrective action real instead of a box-ticking exercise, and which KPIs are actually worth watching.
Looking compliant and being compliant are not the same thing. This one gets into the difference.
Got a pharmacovigilance question of your own? Put it to our experts: https://ivigee.com/#question


Hvezdova 1716/2b, 140 00 Prague 4, Czech Republic
1500 District Avenue, Burlington, MA, United States